Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of escitalopram on morbidity, mortality and mood in depressed chronic heart failure patients
2007-006609-25Phase 4Completed
- Sponsor
- Julius-Maximilians-Universität Würzburg
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic heart failure (CHF) and major depressive disorder (MDD) comparing Escitalopram (Cipralex) with Placebo (2 arms). Primary endpoint: Time to first clinical event (death or hospitalization for any reason). Started Mar 2008; status: completed.
02
Drugs
escitalopram
03
Conditions
chronic heart failure (CHF)major depressive disorder (MDD)
Beyond the preview
Go deeper on 2007-006609-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006609-25.